Journal profile · ENDOCRINOLOGY & METABOLISM
Journal of Diabetology
ISSN 2078-7685 · Wolters Kluwer Medknow Publications · India
Journal of Diabetology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.4 (journal website); JCR Q4 (journal website); diamond open access (no APC); no APC; median 70 days to acceptance (90 articles, last 24 months); 71 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Diabetology is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins and Diabetes Treatment and Management, together about 36.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The Malaysian Obesity Nutrigenetics Environment Study aims to narrow down this gap by integrating multi-omics, clinical, biochemical, body composition, environment, and lifestyle data using machine learning techniques to strengthen population-level precision nutrition strategies for obesity and CMD prevention.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief V. MohanPublisher website
Editorial board by country: none in mainland China; most named India 3 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine16%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10.8%
- Diabetes Treatment and ManagementMedicine9.5%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology8.5%
- Diabetes Management and EducationMedicine7.6%
- Pancreatic function and diabetesMedicine6.2%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology3.5%
- Chronic Disease Management StrategiesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · ENDOCRINOLOGY & METABOLISM · rank 189/198
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.4Publisher website ·
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.17LetPub ·
- SNIP 2026-06
- 0.2LetPub ·
- h-index
- 21OpenAlex ·
- i10-index
- 59OpenAlex ·
- 2-year mean citedness
- 0.83OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 51LetPub ·
Articles by year OpenAlex count · 683 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 61 | 61 | 4 |
| 2025 | 71 | 71 | 60 |
| 2024 | 74 | 74 | 107 |
| 2023 | 56 | 56 | 61 |
| 2022 | 64 | 64 | 170 |
| 2021 | 111 | 111 | 372 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
70 daysMedian, submission to acceptance · P25–P75 50 days – 97 days
- Acceptance to online
- median 102 days (90 articles)
- Submission to online
- median 171 days
- Sample
- 90 articles with submission and acceptance dates (146 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 24 weeksLetPub ·
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- India
- Language
- English
- ISSN
- 2078-7685
- Print ISSN
- 2543-3288
- Latest issue on the website
- Volume 17, Issue 4 (August 2026)
- Official links
FAQ
Frequently asked questions about Journal of Diabetology
What CAS zone is Journal of Diabetology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Diabetology is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Diabetology?
The journal's website gives an impact factor of 0.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 0.7, h-index 21.
How long does peer review take at Journal of Diabetology?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 70 days (interquartile range 50–97 days); authors report an average review time of about 24 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Diabetology in?
The journal's website gives JCR Q4; by category, ENDOCRINOLOGY & METABOLISM Q4 (189/198). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Journal of Diabetology based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Diabetology?
According to LetPub and DOAJ records, Journal of Diabetology is indexed in ESCI, Scopus and DOAJ.
Is Journal of Diabetology open access, and what is the APC?
Journal of Diabetology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .